Three million members of CVS Caremarks clients now enjoy access to clinical weight loss program with proven results, high satisfaction WOONSOCKET, R.I., March 14, 2025 CVS Health (NYSE: CVS) released compelling data today from the CVS Weight Management TM program in which participants achieved more than 15% weight loss on average, including existing anti-obesity medication users who succeeded in nearly doubling their pre-program weight loss while working with program clinicians on diet and lifestyle.* Before enrolling in the CVS Weight Management program, 70% of members were using a weight management drug without any lifestyle or nutrition support.* The initial results demonstrate improved weight loss and high program satisfaction for CVS Caremark clients' plan members trying a lifestyle-first approach and additional clinical effectiveness and cost savings for members receiving clinical support while taking weight management medications like GLP-1s

in this portion of the study, 17 participants received tablet formulations of PF-06882961 or matching placebo at single doses ranging from 3 to 300 mg
Consult your prescriber about combining semaglutide with other medications
And so I think if youre unsure of whats covered or not, like the first place to go and talk to is your pharmacy, Tadrous said
One analyst indicated at the beginning of 2024 that such medicines were on track to be the best-selling class of drugs in 2024, with close to US$50 billion in annual sales